Skip to content

Effects of ropivacaine combined with different opioids for labor analgesia on maternal intrapartum temperature: a randomized, double-blind, parallel-controlled, multicenter study

Effects of ropivacaine combined with different opioids for labor analgesia on maternal intrapartum temperature: a randomized, double-blind, parallel-controlled, multicenter study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064209
Enrollment
Unknown
Registered
2022-09-30
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidural-related maternal fever

Interventions

Sponsors

Women's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. ASA status I-II; 2. Age 18-40 years old 3. Body mass index = 37 weeks 5. Singleton, cephalic, primipara 6. Requires epidural analgesia, and the cervical dilatation is less than or equal to 2cm 7. No contraindications to epidural anesthesia 8. No pregnancy-related diseases such as gestational hypertension, gestational diabetes mellitus 9. No infectious diseases (such as hepatitis B, or syphilis) 10. No abnormal fetal heart rate monitoring before labor analgesia (fetal heart rate range 110-160bpm) 11. The initial body temperature is normal.

Exclusion criteria

Exclusion criteria: 1. The cervical dilatation is >= 3cm when labor analgesia is required 2. Contraindications to spinal anesthesia (eg: abnormal coagulation function, infection at the puncture site) 3. Those who have difficulty in epidural puncture (eg, scoliosis, ankylosing spondylitis) 4. Those who are known to be allergic to the study drug or other drugs used in the study 5. Those who use opioids or other sedative and analgesic drugs within one week, those who use magnesium sulfate and antipyretic drugs 6. Those with a history of drug abuse 7. Patients with sleep apnea syndrome 8. Those with severe heart, lung, liver, and kidney dysfunction 9. Those with symptoms of infection (such as a cold) 10. The amniotic sac has been broken when entering the delivery room

Design outcomes

Primary

MeasureTime frame
Incidence of epidural-related interpartum fever;

Secondary

MeasureTime frame
Maternal body temperature after initiation of epidural labor analgesia;Hourly opioid consumption;Total dosage of analgesic pump after delivery;The duration of amniotic sac rupture;The way of membrane rupture;The number of vaginal digital examination;Labor outcome;Neonatal outcome;

Countries

China

Contacts

Public ContactShqin Xu

Women's Hospital of Nanjing Medical University

xusqnj@126.com+86 13951660028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026